<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Berlin HeidelbergBerlin/Heidelberg 791 doi: 10.1007/s00395-020-0791-5 : Editorial COVID-19 in the" exact="heart" post="and the lungs: could we â€œNotchâ€� the inflammatory storm?"/>
 <result pre="Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of" exact="Advanced" post="Therapies (LTTA), University of Ferrara, [2], 0000 0004 1785"/>
 <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
 <result pre="COVID-19 as a global pandemic. Abstract From January 2020, coronavirus" exact="disease" post="(COVID-19) originated in China has spread around the world."/>
 <result pre="(COVID-19) originated in China has spread around the world. The" exact="disease" post="is caused by the severe acute respiratory syndrome coronavirus"/>
 <result pre="around the world. The disease is caused by the severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2). The presence of myocarditis,"/>
 <result pre="the world. The disease is caused by the severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2). The presence of myocarditis, cardiac"/>
 <result pre="world. The disease is caused by the severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2). The presence of myocarditis, cardiac arrest,"/>
 <result pre="acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The presence of myocarditis," exact="cardiac arrest," post="and acute heart failure in COVID-19 patients suggests the"/>
 <result pre="coronavirus 2 (SARS-CoV-2). The presence of myocarditis, cardiac arrest, and" exact="acute" post="heart failure in COVID-19 patients suggests the existence of"/>
 <result pre="2 (SARS-CoV-2). The presence of myocarditis, cardiac arrest, and acute" exact="heart" post="failure in COVID-19 patients suggests the existence of a"/>
 <result pre="COVID-19 patients suggests the existence of a relationship between SARS-CoV-2" exact="infection" post="and cardiac disease. The Notch signalling is a major"/>
 <result pre="suggests the existence of a relationship between SARS-CoV-2 infection and" exact="cardiac disease." post="The Notch signalling is a major regulator of cardiovascular"/>
 <result pre="cardiac disease. The Notch signalling is a major regulator of" exact="cardiovascular" post="function and it is also implicated in several biological"/>
 <result pre="and it is also implicated in several biological processes mediating" exact="viral" post="infections. In this report we discuss the possibility to"/>
 <result pre="discuss the possibility to target Notch signalling to prevent SARS-CoV-2" exact="infection" post="and interfere with the progression of COVID-19- associated heart"/>
 <result pre="SARS-CoV-2 infection and interfere with the progression of COVID-19- associated" exact="heart" post="and lungs disease. Keywords Coronavirus disease COVID-19 Cardiovascular disease"/>
 <result pre="progression of COVID-19- associated heart and lungs disease. Keywords Coronavirus" exact="disease" post="COVID-19 Cardiovascular disease Angiotensin-converting enzyme 2 Furin ADAM17 Notch"/>
 <result pre="associated heart and lungs disease. Keywords Coronavirus disease COVID-19 Cardiovascular" exact="disease" post="Angiotensin-converting enzyme 2 Furin ADAM17 Notch On COVID-19 and"/>
 <result pre="Angiotensin-converting enzyme 2 Furin ADAM17 Notch On COVID-19 and the" exact="heart" post="From January 2020, coronavirus disease (COVID-19) has spread fast"/>
 <result pre="Notch On COVID-19 and the heart From January 2020, coronavirus" exact="disease" post="(COVID-19) has spread fast from China, mainly to Southwest"/>
 <result pre="and it is now found everywhere around the world. The" exact="disease" post="is caused by Severe Acute Respiratory Syndrome Coronavirus 2"/>
 <result pre="found everywhere around the world. The disease is caused by" exact="Severe" post="Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the seventh member"/>
 <result pre="everywhere around the world. The disease is caused by Severe" exact="Acute" post="Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the seventh member of"/>
 <result pre="around the world. The disease is caused by Severe Acute" exact="Respiratory" post="Syndrome Coronavirus 2 (SARS-CoV-2), the seventh member of the"/>
 <result pre="the world. The disease is caused by Severe Acute Respiratory" exact="Syndrome" post="Coronavirus 2 (SARS-CoV-2), the seventh member of the coronavirus"/>
 <result pre="coronavirus family which infects humans and to which Middle East" exact="Respiratory" post="Syndrome Coronavirus (MERS)-CoV and SARS-CoV also belong [55]. The"/>
 <result pre="family which infects humans and to which Middle East Respiratory" exact="Syndrome" post="Coronavirus (MERS)-CoV and SARS-CoV also belong [55]. The classical"/>
 <result pre="classical clinical picture of COVID-19 is that of a flu-like" exact="syndrome" post="of mild severity in most cases, but in 15%"/>
 <result pre="but in 15% of cases it is complicated by interstitial" exact="pneumonia" post="and a variable degree of respiratory failure [40]. The"/>
 <result pre="is complicated by interstitial pneumonia and a variable degree of" exact="respiratory" post="failure [40]. The underlying pathological changes, responsible for the"/>
 <result pre="respiratory failure [40]. The underlying pathological changes, responsible for the" exact="respiratory" post="failure, have been characterised in two patients who underwent"/>
 <result pre="been characterised in two patients who underwent lung lobotomies for" exact="lung adenocarcinoma" post="and were retrospectively found to be COVID-19 positive [6,"/>
 <result pre="characterised in two patients who underwent lung lobotomies for lung" exact="adenocarcinoma" post="and were retrospectively found to be COVID-19 positive [6,"/>
 <result pre="COVID-19-positive patients, there are those that consult the doctor for" exact="heart" post="symptoms, such as palpitations or chest pain rather than"/>
 <result pre="consult the doctor for heart symptoms, such as palpitations or" exact="chest" post="pain rather than respiratory problems [53]. Little is known"/>
 <result pre="heart symptoms, such as palpitations or chest pain rather than" exact="respiratory" post="problems [53]. Little is known about a possible relationship"/>
 <result pre="Little is known about a possible relationship between COVID-19 and" exact="cardiovascular disease." post="An early report on 99 patients hospitalised from 1st"/>
 <result pre="Jinyntan Hospital, Wuhan, China, for SARS-CoV-2-related pneumonia, shows that pre-existing" exact="cardiovascular disease" post="was present in 40% of them [7]. A second"/>
 <result pre="Hospital, Wuhan, China, for SARS-CoV-2-related pneumonia, shows that pre-existing cardiovascular" exact="disease" post="was present in 40% of them [7]. A second"/>
 <result pre="Among these patients, 16.7% developed arrhythmias and 7.2% experienced an" exact="acute" post="coronary syndrome in addition to other complications [51]. Furthermore,"/>
 <result pre="patients, 16.7% developed arrhythmias and 7.2% experienced an acute coronary" exact="syndrome" post="in addition to other complications [51]. Furthermore, patients diagnosed"/>
 <result pre="in addition to other complications [51]. Furthermore, patients diagnosed with" exact="pneumonia" post="due to SARS-CoV-2 infection showed an increase in high-sensitivity"/>
 <result pre="complications [51]. Furthermore, patients diagnosed with pneumonia due to SARS-CoV-2" exact="infection" post="showed an increase in high-sensitivity cardiac troponin I levels,"/>
 <result pre="Other published and anecdotal reports indicate the presence of myocarditis," exact="cardiac arrest," post="and acute heart failure in SARS-CoV-2- infected patients. It"/>
 <result pre="anecdotal reports indicate the presence of myocarditis, cardiac arrest, and" exact="acute" post="heart failure in SARS-CoV-2- infected patients. It is not"/>
 <result pre="reports indicate the presence of myocarditis, cardiac arrest, and acute" exact="heart" post="failure in SARS-CoV-2- infected patients. It is not clear"/>
 <result pre="pathology with higher cardio-metabolic demand, and thus unrelated to the" exact="viral infection." post="Epidemiological studies conducted during the flu epidemic in USA"/>
 <result pre="1990 show that influenza and its related complications, such as" exact="secondary" post="pneumonia, may cause myocardial infarction due to inflammation-induced destabilisation"/>
 <result pre="and its related complications, such as secondary pneumonia, may cause" exact="myocardial infarction" post="due to inflammation-induced destabilisation of coronary artery plaques [10]."/>
 <result pre="multiple mechanisms, such as tachycardia, hypoxia, increased wall stress, and" exact="thrombophilia" post="or release of inflammatory cytokines [11]. So, a possible"/>
 <result pre="possible causal link cannot be excluded. A similar link with" exact="myocardial infarction" post="and acute heart failure was shown for the recent"/>
 <result pre="cannot be excluded. A similar link with myocardial infarction and" exact="acute" post="heart failure was shown for the recent epidemics of"/>
 <result pre="be excluded. A similar link with myocardial infarction and acute" exact="heart" post="failure was shown for the recent epidemics of SARS-CoV"/>
 <result pre="the recent epidemics of SARS-CoV and MERS-nCoV [53]. In the" exact="absence of" post="a specific treatment or a vaccine, which, according to"/>
 <result pre="possible remedies: (1) attempts to contain the spread of the" exact="infection" post="with drastic and likely unpopular measures, such as quarantine"/>
 <result pre="the summer in the Northern hemisphere; (2) supportive treatment of" exact="respiratory" post="and cardiologic complications of the infection, including admission to"/>
 <result pre="which could help in finding a possible therapy. With our" exact="short" post="report, we would like to contribute with our experience"/>
 <result pre="and the envelope (E) protein, all required to produce the" exact="viral" post="particle [46]. Sequencing analyses on RNA of SARS-CoV-2 variants"/>
 <result pre="coronaviruses, SARS-CoV-2 jumped from bats to humans, probably through an" exact="intermediate" post="host, not yet identified, after the occurrence of a"/>
 <result pre="identified, after the occurrence of a mutation that allowed the" exact="infection" post="of human cells [3]. The S (spike) glycoprotein mediates"/>
 <result pre="ACE2 is mainly located in the inner track of the" exact="respiratory" post="system, thus explaining why SARS-CoV-2, differently from the flu"/>
 <result pre="SARS-CoV-2, differently from the flu virus which binds to the" exact="upper" post="airways track, might cause serious respiratory insufficiency. This also"/>
 <result pre="which binds to the upper airways track, might cause serious" exact="respiratory" post="insufficiency. This also explains why COVID-19 is not just"/>
 <result pre="II receptor blockers (ARBs), which are widely used to treat" exact="hypertension" post="and heart failure, increase the levels of Ang II"/>
 <result pre="receptor blockers (ARBs), which are widely used to treat hypertension" exact="and heart" post="failure, increase the levels of Ang II [44] and,"/>
 <result pre="blockers (ARBs), which are widely used to treat hypertension and" exact="heart" post="failure, increase the levels of Ang II [44] and,"/>
 <result pre="It has been proposed that patients receiving ARBs have higher" exact="susceptibility to" post="COVID-19 [15] and, as a consequence, hypertensive or patients"/>
 <result pre="COVID-19 [15] and, as a consequence, hypertensive or patients with" exact="heart" post="failure should switch from ARBs to other drugs. This"/>
 <result pre="there are caveats here: (1) ACE2 expression is reduced in" exact="hypertension" post="models; (2) there is no evidence of increased ACE2"/>
 <result pre="of increased ACE2 expression with ARBs in the lung; (3)" exact="hypertension" post="and its treatment with ARBs did not affect previous"/>
 <result pre="and its treatment with ARBs did not affect previous coronavirus" exact="infections" post="[16]. Based on the evidence discussed above, ACE2 could"/>
 <result pre="SARS-CoV and SARS-CoV-2 in vitro [27]. Another approach to prevent" exact="viral infection" post="could be the downregulation of ACE2 on cell membrane."/>
 <result pre="and SARS-CoV-2 in vitro [27]. Another approach to prevent viral" exact="infection" post="could be the downregulation of ACE2 on cell membrane."/>
 <result pre="Metalloproteases 17), a metalloprotease significantly expressed also in the lungs" exact="and heart," post="is involved in the shedding of surface proteins, including"/>
 <result pre="agent 5-fluorouracil strongly activates ADAM17 in an animal model of" exact="colorectal cancer" post="[25]. Furthermore, in non-small cell lung cancer cell lines,"/>
 <result pre="5-fluorouracil strongly activates ADAM17 in an animal model of colorectal" exact="cancer" post="[25]. Furthermore, in non-small cell lung cancer cell lines,"/>
 <result pre="animal model of colorectal cancer [25]. Furthermore, in non-small cell" exact="lung cancer" post="cell lines, estradiol increases the expression levels and activity"/>
 <result pre="model of colorectal cancer [25]. Furthermore, in non-small cell lung" exact="cancer" post="cell lines, estradiol increases the expression levels and activity"/>
 <result pre="COVID-19 in women compared to men [19]. Fig. 1 a" exact="Severe" post="acute respiratory syndrome- coronavirus-2 (SARS-CoV-2) entry into the cells"/>
 <result pre="in women compared to men [19]. Fig. 1 a Severe" exact="acute" post="respiratory syndrome- coronavirus-2 (SARS-CoV-2) entry into the cells is"/>
 <result pre="women compared to men [19]. Fig. 1 a Severe acute" exact="respiratory" post="syndrome- coronavirus-2 (SARS-CoV-2) entry into the cells is mediated"/>
 <result pre="into the cells is mediated by the binding of the" exact="viral" post="spike (S) glycoprotein to the angiotensin converting enzyme 2"/>
 <result pre="family that processes protein of the secretory pathway, is a" exact="type 1" post="membrane-bound protease that is expressed in multiple organs, including"/>
 <result pre="furin-mediated proteolytic cut of the S protein is necessary for" exact="viral" post="entry into the cell [50]. Inhibiting the expression of"/>
 <result pre="furin could then be a possible approach to prevent SARS-CoV-2" exact="infection" post="(Fig.Â 1a, b). Of relevance in this context, nanomolar"/>
 <result pre="a peptide designed from the furin cleavage sequence of the" exact="avian influenza" post="A H5N1 virus provide protection against infection by several"/>
 <result pre="of the avian influenza A H5N1 virus provide protection against" exact="infection" post="by several furin-dependent pathogens [47]. Furin and ADAM17 are"/>
 <result pre="66 potential cellular proteins that could be targeted to prevent" exact="viral infection" post="[13]. With this approach, it is impossible to identify"/>
 <result pre="potential cellular proteins that could be targeted to prevent viral" exact="infection" post="[13]. With this approach, it is impossible to identify"/>
 <result pre="approach, it is impossible to identify host proteins crucial for" exact="viral infection," post="which do not interact directly with viral proteins, as"/>
 <result pre="crucial for viral infection, which do not interact directly with" exact="viral" post="proteins, as is the case for furin and ADAM17."/>
 <result pre="therapeutic targets to treat COVID-19. Targeting Notch to prevent SARS-CoV-2" exact="infection" post="The Notch signalling pathway plays a major role in"/>
 <result pre="Notch signalling is involved in maintaining the homeostasis of the" exact="cardiovascular" post="system and could represent a novel target to reduce"/>
 <result pre="cardiovascular system and could represent a novel target to reduce" exact="atherosclerosis" post="progression [18, 42] and remodelling following a myocardial infarction"/>
 <result pre="to reduce atherosclerosis progression [18, 42] and remodelling following a" exact="myocardial infarction" post="[17, 20, 34]. In humans, there are four receptors"/>
 <result pre="then, be useful to reduce furin levels and interfere with" exact="viral" post="entry into the cell. Since Notch dysregulation is a"/>
 <result pre="tested, with manageable gastrointestinal toxicity, in several clinical trials in" exact="cancer" post="patients. Favorable response has been so far obtained in"/>
 <result pre="patients. Favorable response has been so far obtained in a" exact="limited" post="number of patients indicating that it will be crucial"/>
 <result pre="to develop new strategies to identify â€œrespondersâ€� to Notch inhibition-based" exact="cancer" post="therapies [2]. Notch1-dependent enhancement of furin activity activates ADAM10"/>
 <result pre="downregulates ADAM17 [14], is a target of Jagged1/Notch1 signalling in" exact="vascular" post="smooth muscle cells [4]. It would be of interest"/>
 <result pre="[14], is a target of Jagged1/Notch1 signalling in vascular smooth" exact="muscle" post="cells [4]. It would be of interest to investigate"/>
 <result pre="is a â€œcytokine stormâ€� triggered by an imbalanced response by" exact="type 1" post="and type 2Â T helper (Th) cells [53]. The"/>
 <result pre="against the IL-6 receptor (tocilizumab, Roche) in patients with COVID-19" exact="pneumonia" post="and elevated IL-6 has been conducted in China with"/>
 <result pre="the efficacy of tocilizumab in 330 Italian patients with COVID-19" exact="pneumonia" post="has been approved by the Italian Medicines Agency (https://www.agenziafarmaco.gov.it/en)"/>
 <result pre="that Notch inhibition could interfere with the immune response during" exact="viral infection." post="Ito et al. [24] found that in mice infected"/>
 <result pre="or GSI by intranasal administration, resulted in increased mortality, defective" exact="viral" post="clearance, and decreased IFN-Î³ production in lungs [24]. Notch"/>
 <result pre="lungs [24]. Notch signalling also modulates the immune response following" exact="respiratory" post="syncytial virus (RSV) infection [28]. Of note, it has"/>
 <result pre="also modulates the immune response following respiratory syncytial virus (RSV)" exact="infection" post="[28]. Of note, it has been reported that RSV"/>
 <result pre="infection [28]. Of note, it has been reported that RSV" exact="infection" post="causes an increase of Jagged1 in bronchial epithelial cells"/>
 <result pre="that RSV infection causes an increase of Jagged1 in bronchial" exact="epithelial" post="cells and, when co-cultured with CD4â€‰+â€‰T cells, promotes Th2"/>
 <result pre="efficiently inhibit neointima formation after balloon injury by decreasing smooth" exact="muscle" post="cell proliferation and migration through inhibition of Notch signalling"/>
 <result pre="Notch inhibition can be useful not only for treatment of" exact="atherosclerosis" post="but also for other inflammation-based conditions such as graft-versus-host"/>
 <result pre="atherosclerosis but also for other inflammation-based conditions such as graft-versus-host" exact="disease" post="[39], chronic obstructive pulmonary disease (COPD) [12] and arthritis"/>
 <result pre="also for other inflammation-based conditions such as graft-versus-host disease [39]," exact="chronic" post="obstructive pulmonary disease (COPD) [12] and arthritis [31]. It"/>
 <result pre="other inflammation-based conditions such as graft-versus-host disease [39], chronic obstructive" exact="pulmonary" post="disease (COPD) [12] and arthritis [31]. It is important"/>
 <result pre="inflammation-based conditions such as graft-versus-host disease [39], chronic obstructive pulmonary" exact="disease" post="(COPD) [12] and arthritis [31]. It is important to"/>
 <result pre="conditions such as graft-versus-host disease [39], chronic obstructive pulmonary disease" exact="(COPD)" post="[12] and arthritis [31]. It is important to point"/>
 <result pre="graft-versus-host disease [39], chronic obstructive pulmonary disease (COPD) [12] and" exact="arthritis" post="[31]. It is important to point out that before"/>
 <result pre="these patients, we should address issues that could arise upon" exact="chronic" post="exposure to Notch inhibitors, likely required for many of"/>
 <result pre="amyloid A4 peptide [2, 35]. A possible approach to avoid" exact="systemic" post="toxicity could be delivery of GSIs and Jagged1/Dll4 inhibitors"/>
 <result pre="is well documented. To replicate, some viruses, such as Human" exact="Papilloma" post="Virus and Simian Virus 40, highjack the cell machinery,"/>
 <result pre="the Notch signalling, and by doing so they can cause" exact="cancer" post="[9]. Therefore, it has been proposed that the dysregulation"/>
 <result pre="we might be able to target Notch also to fight" exact="heart" post="and lung disease caused directly by SARS-CoV-2 infection and"/>
 <result pre="be able to target Notch also to fight heart and" exact="lung disease" post="caused directly by SARS-CoV-2 infection and by the cytokine"/>
 <result pre="able to target Notch also to fight heart and lung" exact="disease" post="caused directly by SARS-CoV-2 infection and by the cytokine"/>
 <result pre="to fight heart and lung disease caused directly by SARS-CoV-2" exact="infection" post="and by the cytokine storm in response to the"/>
 <result pre="2.AquilaGKostinaAVieceli Dalla SegaFShlyakhtoEKostarevaAMarracinoLFerrariRRizzoPMalaschichevaAThe Notch pathway: a novel therapeutic target for" exact="cardiovascular" post="diseases?Expert Opin Ther Targets20192369571010.1080/14728222.2019.164119831304807 3.BenvenutoDGiovanettiMCiccozziASpotoSAngelettiSCiccozziMThe 2019-new coronavirus epidemic: evidence"/>
 <result pre="cluster is a novel transcriptional target of Jagged-1/Notch signaling in" exact="vascular" post="smooth muscle cellsJ Biol Chem2011286283122832110.1074/jbc.M111.22194521685392 5.CaoloVSchultenHMZhuangZWMurakamiMWagenaarAVerbruggenSMolinDGPostMJSoluble Jagged-1 inhibits neointima"/>
 <result pre="a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth" exact="muscle" post="cellsJ Biol Chem2011286283122832110.1074/jbc.M111.22194521685392 5.CaoloVSchultenHMZhuangZWMurakamiMWagenaarAVerbruggenSMolinDGPostMJSoluble Jagged-1 inhibits neointima formation by"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 8.ChengJKoenigSNKuivaniemiHSGargVHansCPPharmacological inhibitor of"/>
 <result pre="8.ChengJKoenigSNKuivaniemiHSGargVHansCPPharmacological inhibitor of notch signaling stabilizes the progression of small" exact="abdominal aortic aneurysm" post="in a mouse modelJ Am Heart Assoc20143e00106410.1161/JAHA.114.00106425349182 9.AaRPaMFaTMCRoles of"/>
 <result pre="inhibitor of notch signaling stabilizes the progression of small abdominal" exact="aortic aneurysm" post="in a mouse modelJ Am Heart Assoc20143e00106410.1161/JAHA.114.00106425349182 9.AaRPaMFaTMCRoles of"/>
 <result pre="of notch signaling stabilizes the progression of small abdominal aortic" exact="aneurysm" post="in a mouse modelJ Am Heart Assoc20143e00106410.1161/JAHA.114.00106425349182 9.AaRPaMFaTMCRoles of"/>
 <result pre="of small abdominal aortic aneurysm in a mouse modelJ Am" exact="Heart" post="Assoc20143e00106410.1161/JAHA.114.00106425349182 9.AaRPaMFaTMCRoles of dysregulated Notch pathway and small DNA"/>
 <result pre="Heart Assoc20143e00106410.1161/JAHA.114.00106425349182 9.AaRPaMFaTMCRoles of dysregulated Notch pathway and small DNA" exact="tumor" post="viruses in cancer initiation and progressionJ Cancer Metastasis Treat201510.4103/2394-4722.171982"/>
 <result pre="of dysregulated Notch pathway and small DNA tumor viruses in" exact="cancer" post="initiation and progressionJ Cancer Metastasis Treat201510.4103/2394-4722.171982 10.CollinsSDExcess mortality from"/>
 <result pre="and small DNA tumor viruses in cancer initiation and progressionJ" exact="Cancer" post="Metastasis Treat201510.4103/2394-4722.171982 10.CollinsSDExcess mortality from causes other than influenza"/>
 <result pre="Metastasis Treat201510.4103/2394-4722.171982 10.CollinsSDExcess mortality from causes other than influenza and" exact="pneumonia" post="during influenza epidemicsPublic Health Rep1932472159217910.2307/458060619315373 11.Corrales-MedinaVFMadjidMMusherDMRole of acute infection"/>
 <result pre="influenza and pneumonia during influenza epidemicsPublic Health Rep1932472159217910.2307/458060619315373 11.Corrales-MedinaVFMadjidMMusherDMRole of" exact="acute" post="infection in triggering acute coronary syndromesLancet Infect Dis201010839210.1016/S1473-3099(09)70331-720113977 12.DanahayHPessottiADCooteJMontgomeryBEXiaDWilsonAYangHWangZBevanLThomasCPetitSLondonALeMottePDoelemeyerAVÃ©lez-ReyesGLBernasconiPFryerCJEdwardsMCapodieciPChenAHildMJaffeABNotch2"/>
 <result pre="and pneumonia during influenza epidemicsPublic Health Rep1932472159217910.2307/458060619315373 11.Corrales-MedinaVFMadjidMMusherDMRole of acute" exact="infection" post="in triggering acute coronary syndromesLancet Infect Dis201010839210.1016/S1473-3099(09)70331-720113977 12.DanahayHPessottiADCooteJMontgomeryBEXiaDWilsonAYangHWangZBevanLThomasCPetitSLondonALeMottePDoelemeyerAVÃ©lez-ReyesGLBernasconiPFryerCJEdwardsMCapodieciPChenAHildMJaffeABNotch2 is"/>
 <result pre="influenza epidemicsPublic Health Rep1932472159217910.2307/458060619315373 11.Corrales-MedinaVFMadjidMMusherDMRole of acute infection in triggering" exact="acute" post="coronary syndromesLancet Infect Dis201010839210.1016/S1473-3099(09)70331-720113977 12.DanahayHPessottiADCooteJMontgomeryBEXiaDWilsonAYangHWangZBevanLThomasCPetitSLondonALeMottePDoelemeyerAVÃ©lez-ReyesGLBernasconiPFryerCJEdwardsMCapodieciPChenAHildMJaffeABNotch2 is required for inflammatory"/>
 <result pre="drug-repurposingBioRxiv202010.1101/2020.03.22.002386 14.DobersteinKSteinmeyerNHartmetzAKEberhardtWMittelbronnMHarterPNJuengelEBlahetaRPfeilschifterJGutweinPMicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in" exact="renal cell carcinoma" post="patientsNeoplasia20131521823010.1593/neo.12122223441135 15.FangLKarakiulakisGRothMAre patients with hypertension and diabetes mellitus at"/>
 <result pre="targets the metalloprotease ADAM17 and is suppressed in renal cell" exact="carcinoma" post="patientsNeoplasia20131521823010.1593/neo.12122223441135 15.FangLKarakiulakisGRothMAre patients with hypertension and diabetes mellitus at"/>
 <result pre="is suppressed in renal cell carcinoma patientsNeoplasia20131521823010.1593/neo.12122223441135 15.FangLKarakiulakisGRothMAre patients with" exact="hypertension" post="and diabetes mellitus at increased risk for COVID-19 infection?Lancet"/>
 <result pre="in renal cell carcinoma patientsNeoplasia20131521823010.1593/neo.12122223441135 15.FangLKarakiulakisGRothMAre patients with hypertension and" exact="diabetes mellitus" post="at increased risk for COVID-19 infection?Lancet Respir Med202010.1016/S2213-2600(20)30116-832222169 16.Ferrari"/>
 <result pre="17.FerrariRRizzoPThe Notch pathway: a novel target for myocardial remodelling therapy?Eur" exact="Heart" post="J2014352140214510.1093/eurheartj/ehu24424970336 18.FortiniFVieceli Dalla SegaFCalicetiCLambertiniEPannutiAPeifferDSBallaCRizzoPEstrogen-mediated protection against coronary heart disease:"/>
 <result pre="remodelling therapy?Eur Heart J2014352140214510.1093/eurheartj/ehu24424970336 18.FortiniFVieceli Dalla SegaFCalicetiCLambertiniEPannutiAPeifferDSBallaCRizzoPEstrogen-mediated protection against coronary" exact="heart" post="disease: the role of the Notch pathwayJ Steroid Biochem"/>
 <result pre="Steroid Biochem Mol Biol20191898710010.1016/j.jsbmb.2019.02.00830817989 19.GuanWJNiZYHuYLiangWHOuCQHeJXLiuLShanHLeiCLHuiDSCDuBLiLJZengGYuenKYChenRCTangCLWangTChenPYXiangJLiSYWangJLLiangZJPengYXWeiLLiuYHuYHPengPWangJMLiuJYChenZLiGZhengZJQiuSQLuoJYeCJZhuSYZhongNScollab: Covid-19 CMTEGfClinical Characteristics of Coronavirus" exact="Disease" post="2019 in ChinaN Engl J Med202010.1056/NEJMoa200203232220206 20.GudeNJoyoETokoHQuijadaPVillanuevaMHariharanNSacchiVTruffaSJoyoAVoelkersMAlvarezRSussmanMANotch activation enhances"/>
 <result pre="21.HildebrandDUhleFSahinDKrauserUWeigandMAHeegKThe interplay of notch signaling and STAT3 in TLR-activated human" exact="primary" post="monocytesFront Cell Infect Microbiol2018824110.3389/fcimb.2018.0024130042932 22.HoffmannMKleine-WeberHSchroederSKrÃ¼gerNHerrlerTErichsenSSchiergensTSHerrlerGWuNHNitscheAMÃ¼llerMADrostenCPÃ¶hlmannSSARS-CoV-2 cell entry depends on"/>
 <result pre="ADAM-17: a novel mechanism of drug resistance in colorectal cancerClin" exact="Cancer" post="Res2010163378338910.1158/1078-0432.CCR-10-001420570921 26.LambertDWYarskiMWarnerFJThornhillPParkinETSmithAIHooperNMTurnerAJTumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain"/>
 <result pre="factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute" exact="respiratory" post="syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)J Biol Chem2005280301133011910.1074/jbc.M50511120015983030 27.LeiCFuWQianKLiTZhangSDingMHuSPotent"/>
 <result pre="2019 novel coronavirus by recombinant ACE2-IgBiorxiv202010.1101/2020.02.01.929976 28.LukacsNWSmitJJSchallerMALindellDMRegulation of immunity to" exact="respiratory" post="syncytial virus by dendritic cells, toll-like receptors, and notchViral"/>
 <result pre="29.MolanoFDArevalo-RodriguezIRoquÃ© i FigulsMMontero OleasNNuvialsXZamoraJLevels of interleukin-6 in identifying severely ill" exact="adult" post="patients with sepsisCochrane202010.1002/14651858.CD011811 30.OsborneBAMinterLMNotch signalling during peripheral T-cell activation"/>
 <result pre="identifying severely ill adult patients with sepsisCochrane202010.1002/14651858.CD011811 30.OsborneBAMinterLMNotch signalling during" exact="peripheral" post="T-cell activation and differentiationNat Rev Immunol20077647510.1038/nri199817170755 31.ParkJSKimSHKimKJinCHChoiKYJangJChoiYGwonARBaikSHYunUJChaeSYLeeSKangYMLeeKCArumugamTVMattsonMPParkJHJoDGInhibition of notch"/>
 <result pre="stressBasic Res Cardiol201310837310.1007/s00395-013-0373-x23989801 35.PenninkilampiRBrothersHMEslickGDPharmacological agents targeting Î³-secretase increase risk of" exact="cancer" post="and cognitive decline in alzheimer's disease patients: a systematic"/>
 <result pre="Î³-secretase increase risk of cancer and cognitive decline in alzheimer's" exact="disease" post="patients: a systematic review and meta-analysisJ Alzheimers Dis2016531395140410.3233/JAD-16027527392862 36.QinCZhouLHuZZhangSYangSTaoYXieCMaKShangKWangWTianDSDysregulation"/>
 <result pre="decline in alzheimer's disease patients: a systematic review and meta-analysisJ" exact="Alzheimers" post="Dis2016531395140410.3233/JAD-16027527392862 36.QinCZhouLHuZZhangSYangSTaoYXieCMaKShangKWangWTianDSDysregulation of immune response in patients with COVID-19"/>
 <result pre="in patients with COVID-19 in Wuhan, ChinaClin Infect Dis202010.1093/cid/ciaa24832255183 37.QinLQiuKZHuCPWuGJWangLLTanYRBronchial" exact="epithelial" post="cells promote the differentiation of Th2 lymphocytes in airway"/>
 <result pre="sustains notch1 signaling by processing notch1-activating proteases ADAM10 and membrane" exact="type 1" post="matrix metalloproteinaseMol Cell Biol2015353622363210.1128/MCB.00116-1526283728 39.RadojcicVMaillardINotch signaling and alloreactivityTransplantation20161002593260010.1097/TP.000000000000146827607530 40.RapezziCFerrariRThe"/>
 <result pre="40.RapezziCFerrariRThe Cardiologist at the time of Coronavirus: a perfect stormEur" exact="Heart" post="J.2020411320132210.1093/eurheartj/ehaa23332236465 41.RenJNieYLvMShenSTangRXuYHouYZhaoSWangTEstrogen upregulates MICA/B expression in human non-small cell"/>
 <result pre="Heart J.2020411320132210.1093/eurheartj/ehaa23332236465 41.RenJNieYLvMShenSTangRXuYHouYZhaoSWangTEstrogen upregulates MICA/B expression in human non-small cell" exact="lung cancer" post="through the regulation of ADAM17Cell Mol Immunol20151276877610.1038/cmi.2014.10125363527 42.RizzoPMieleLFerrariRThe notch"/>
 <result pre="J.2020411320132210.1093/eurheartj/ehaa23332236465 41.RenJNieYLvMShenSTangRXuYHouYZhaoSWangTEstrogen upregulates MICA/B expression in human non-small cell lung" exact="cancer" post="through the regulation of ADAM17Cell Mol Immunol20151276877610.1038/cmi.2014.10125363527 42.RizzoPMieleLFerrariRThe notch"/>
 <result pre="a crossroad between the life and death of the endotheliumEur" exact="Heart" post="J2013342504250910.1093/eurheartj/ehs14122645188 43.RuanQYangKWangWJiangLSongJClinical predictors of mortality due to COVID-19 based"/>
 <result pre="host cell furin proprotein convertases as a therapeutic strategy against" exact="bacterial" post="toxins and viral pathogensJ Biol Chem2007282208472085310.1074/jbc.M70384720017537721 48.TianSHuWNiuLLiuHXuHXiaoSYPulmonary pathology of"/>
 <result pre="proprotein convertases as a therapeutic strategy against bacterial toxins and" exact="viral" post="pathogensJ Biol Chem2007282208472085310.1074/jbc.M70384720017537721 48.TianSHuWNiuLLiuHXuHXiaoSYPulmonary pathology of early phase 2019"/>
 <result pre="Chem2007282208472085310.1074/jbc.M70384720017537721 48.TianSHuWNiuLLiuHXuHXiaoSYPulmonary pathology of early phase 2019 novel coronavirus (COVID-19)" exact="pneumonia" post="in two patients with lung cancerJ Thorac Oncol202010.1016/j.jtho.2020.02.01032114094 49.Vieceli"/>
 <result pre="51.WangDHuBHuCZhuFLiuXZhangJWangBXiangHChengZXiongYZhaoYLiYWangXPengZClinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected" exact="pneumonia" post="in Wuhan. ChinaJAMA202010.1001/jama.2020.158532259222 52.WongchanaWPalagaTDirect regulation of interleukin-6 expression by"/>
 <result pre="by Notch signaling in macrophagesCell Mol Immunol2012915516210.1038/cmi.2011.3621983868 53.ZhengYYMaYTZhangJYXieXCOVID-19 and the" exact="cardiovascular" post="systemNat Rev Cardiol202010.1038/s41569-020-0360-532231330 54.ZhouPYangXLWangXGHuBZhangLZhangWSiHRZhuYLiBHuangCLChenHDChenJLuoYGuoHJiangRDLiuMQChenYShenXRWangXZhengXSZhaoKChenQJDengFLiuLLYanBZhanFXWangYYXiaoGFShiZLA pneumonia outbreak associated with a"/>
 <result pre="Mol Immunol2012915516210.1038/cmi.2011.3621983868 53.ZhengYYMaYTZhangJYXieXCOVID-19 and the cardiovascular systemNat Rev Cardiol202010.1038/s41569-020-0360-532231330 54.ZhouPYangXLWangXGHuBZhangLZhangWSiHRZhuYLiBHuangCLChenHDChenJLuoYGuoHJiangRDLiuMQChenYShenXRWangXZhengXSZhaoKChenQJDengFLiuLLYanBZhanFXWangYYXiaoGFShiZLA" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="bat originNature202057927027310.1038/s41586-020-2012-732015507 55.ZhuNZhangDWangWLiXYangBSongJZhaoXHuangBShiWLuRNiuPZhanFMaXWangDXuWWuGGaoGFTanWcollab: Team CNCIaRA Novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med202038272773310.1056/NEJMoa200101731978945"/>
</results>
